HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kusumam Joseph Selected Research

Prekallikrein

7/2017Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
10/2016Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
8/2013Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
9/2008Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kusumam Joseph Research Topics

Disease

14Hereditary Angioedemas
06/2021 - 01/2002
10Angioedema
02/2022 - 01/2002
4Choroidal Neovascularization
01/2021 - 05/2013
4Asthma (Bronchial Asthma)
09/2008 - 01/2002
3Inflammation (Inflammations)
11/2011 - 02/2002
3Chronic Urticaria
09/2008 - 04/2005
2Urticaria (Hives)
07/2015 - 09/2008
2Macular Degeneration (Age-Related Maculopathy)
01/2015 - 05/2013
2Anaphylaxis (Anaphylactic Shock)
01/2014 - 02/2002
2Alzheimer Disease (Alzheimer's Disease)
01/2014 - 01/2005
1Thrombosis (Thrombus)
06/2021
1Retinal Degeneration
01/2021
1Infections
07/2017
1Neoplasms (Cancer)
11/2016
1Hypersensitivity (Allergy)
01/2014
1Hereditary Angioedema Types I and II
08/2013
1Stroke (Strokes)
01/2005
1Cough
01/2005
1Septic Shock (Toxic Shock Syndrome)
01/2005
1Nasal Polyps (Nasal Polyp)
11/2004
1Polyps
11/2004
1Allergic Rhinitis
02/2002
1Hypotension (Low Blood Pressure)
02/2002
1Hypertension (High Blood Pressure)
02/2002
1Heart Failure
02/2002
1Bronchial Hyperreactivity
01/2002

Drug/Important Bio-Agent (IBA)

12BradykininIBA
06/2021 - 01/2002
5Complement System Proteins (Complement)IBA
01/2021 - 04/2005
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2015 - 01/2002
4PrekallikreinIBA
07/2017 - 09/2008
4Factor XII (Hageman Factor)IBA
10/2016 - 09/2008
3KininsIBA
11/2016 - 06/2010
2CytokinesIBA
07/2017 - 11/2004
2A-factor (Streptomyces)IBA
07/2017 - 01/2016
2High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA
07/2017 - 09/2008
2Kallikreins (Kallikrein)IBA
10/2016 - 08/2013
2Factor XIIa (Coagulation Factor XIIa)IBA
10/2016 - 03/2010
2Omalizumab (Xolair)FDA Link
07/2015 - 09/2008
2Proteins (Proteins, Gene)FDA Link
01/2014 - 01/2010
2AutoantibodiesIBA
09/2008 - 09/2007
2Immunoglobulin G (IgG)IBA
09/2008 - 04/2005
2IgE Receptors (Fc epsilon RI)IBA
09/2008 - 04/2005
1Indicators and Reagents (Reagents)IBA
02/2022
1Monoclonal AntibodiesIBA
02/2022
1Immunoglobulin M (IgM)IBA
01/2021
1SmokeIBA
01/2021
1AndrogensIBA
01/2021
1Interleukin-1 (Interleukin 1)IBA
07/2017
1Estrogens (Estrogen)FDA Link
07/2017
1FibrinolysinFDA Link
07/2017
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2017
1PlasminogenIBA
07/2017
1PlasticsIBA
10/2016
1AnaphylatoxinsIBA
03/2016
1Plasminogen Activator Inhibitor 2IBA
01/2016
1Angiotensin Receptor AntagonistsIBA
06/2015
1EnalaprilFDA LinkGeneric
06/2015
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
06/2015
1Complement Factor B (Factor B)IBA
01/2015
1Histamine (Histamine Dihydrochloride)FDA Link
01/2014
1Proteoglycans (Proteoglycan)IBA
01/2014
1Amyloid (Amyloid Fibrils)IBA
01/2014
1CryoglobulinsIBA
01/2014
1Phospholipids (Phosphatides)FDA LinkGeneric
05/2013
1AntibodiesIBA
05/2013
1Pharmaceutical PreparationsIBA
11/2011
1Plasma KallikreinIBA
03/2010
1Blood Proteins (Serum Proteins)IBA
03/2010
1KaolinIBA
09/2008
1Immunoglobulin E (IgE)IBA
09/2008
1SteroidsIBA
11/2004
1Chemotactic FactorsIBA
11/2004
1Interleukin-13IBA
11/2004
1ChemokinesIBA
11/2004
1Interleukin-5 (Interleukin 5)IBA
11/2004
1Heparin (Liquaemin)FDA LinkGeneric
02/2002

Therapy/Procedure

2Therapeutics
01/2021 - 07/2015
2Lasers (Laser)
01/2015 - 05/2013